Badreddin Edris - Chief Operating Officer, Springworks Therapeutics, Inc
As of July 1, 2021
Badreddin Edris Net Worth
- Net worth is estimated to be at least $29.47M
- Owns at least 301,541 units of Springworks Therapeutics, Inc stock
- Sold an estimated value of $5.42M in the last year at Springworks Therapeutics, Inc
Badreddin Edris Compensation at Springworks Therapeutics, Inc in 2020
- Earned a $409,500 salary
- Received a total compensation of $2,744,080
Badreddin Edris Trading
- Largest sale of shares was 32,000 units , worth over $2.73M on July 1, 2021
- In total has made about 4 transactions over a year
- Usually trades in January, with the busiest year in 2021
Badreddin Edris
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
Badreddin Edris Mailing Address
- Mailing address is C/o Springworks Therapeutics, Inc. 100 Washington Blvd. Stamford CT 06902 CT
Springworks Therapeutics, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| Saqib Islam, J.D., | 2020 | $540,750 | - | - | $6,788,860 | $405,563 | - | $7,735,173 |
| Saqib Islam, J.D., | 2019 | $480,115 | - | - | $2,470,056 | $334,750 | - | $3,284,921 |
| Saqib Islam, J.D., | 2018 | $406,510 | - | $1,181,322 | - | $180,000 | - | $1,767,832 |
| Francis I. Perier, Jr., M.B.A., | 2020 | $405,600 | - | - | $1,566,660 | $243,360 | - | $2,215,620 |
| Francis I. Perier, Jr., M.B.A., | 2019 | $144,583 | - | - | $2,150,821 | $77,231 | - | $2,372,635 |
| Badreddin Edris, Ph.D., | 2020 | $409,500 | - | - | $2,088,880 | $245,700 | - | $2,744,080 |
| Badreddin Edris, Ph.D., | 2019 | $377,609 | - | - | $222,126 | $202,800 | $107,895 | $910,430 |
| Badreddin Edris, Ph.D., | 2018 | $112,500 | - | $339,900 | - | $33,140 | $37,735 | $523,275 |
| L. Mary Smith, Ph.D., | 2020 | $409,500 | - | - | $1,566,660 | $245,700 | - | $2,221,860 |
| L. Mary Smith, Ph.D., | 2019 | $369,784 | - | - | $180,051 | $202,800 | - | $752,636 |
| L. Mary Smith, Ph.D., | 2018 | $279,865 | - | $123,644 | - | $79,000 | - | $482,509 |
| Herschel S. Weinstein, J.D. | 2020 | $348,333 | - | - | $2,256,594 | $194,180 | - | $2,799,107 |
| Daniel Pichl, | 2020 | $145,833 | - | - | $2,095,305 | $73,990 | - | $2,315,128 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1773427/000110465921050515/tm2110663-2_def14a.htm
Springworks Therapeutics, Inc Insider Trading
- The most recent transaction was 1,000,000 units sold on August 12, 2021 by Bain Capital Life Sciences Investors Llc, BC Sw Lp, Lawrence Jeffrey Schwartz and Adam Koppel worth over $70.25M
- In the last 2 years, insiders at Springworks Therapeutics, Inc sold an estimated value of $312.12M and bought an estimated value of $14.57M
- The most active traders are Orbimed Advisors Llc, Orbimed Capital GP Vi Llc, and Stephen Squinto, Director
- Insider trading is most common in May, with the busiest year in 2021
SpringWorks Therapeutics, Inc. Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||